Ropes & Gray represented Cullinan Oncology in the deal. Cullinan Oncology announced a strategic collaboration with Taiho Pharmaceutical under which Taiho will acquire Cullinan Oncology’s subsidiary Cullinan...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Ovid Therapeutics on the deal. Ovid Therapeutics announced a strategic partnership with U.K.-based Healx, an AI-powered technology company, that granted Healx the...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Blueprint Medicines in the deal. Blueprint Medicines annunced an exclusive collaboration and licensing agreement with Zai Lab Limited for the development and...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised iTeos Therapeutics in the deal. iTeos Therapeutics closed a collaboration with global healthcare leader GSK to co-develop and co-commercialize an anti-TIGIT monoclonal...
You must be a Standard 1 Year member to access this content.
